Cargando…
Nostocyclopeptides as New Inhibitors of 20S Proteasome
Nostocyclopeptides (Ncps) are a small class of bioactive nonribosomal peptides produced solely by cyanobacteria of the genus Nostoc. In the current work, six Ncps were isolated from Nostoc edaphicum strain CCNP1411. The bioactivity of these compounds was tested in vitro against 20S proteasome, a pro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533403/ https://www.ncbi.nlm.nih.gov/pubmed/34680116 http://dx.doi.org/10.3390/biom11101483 |
_version_ | 1784587304442003456 |
---|---|
author | Fidor, Anna Cekała, Katarzyna Wieczerzak, Ewa Cegłowska, Marta Kasprzykowski, Franciszek Edwards, Christine Mazur-Marzec, Hanna |
author_facet | Fidor, Anna Cekała, Katarzyna Wieczerzak, Ewa Cegłowska, Marta Kasprzykowski, Franciszek Edwards, Christine Mazur-Marzec, Hanna |
author_sort | Fidor, Anna |
collection | PubMed |
description | Nostocyclopeptides (Ncps) are a small class of bioactive nonribosomal peptides produced solely by cyanobacteria of the genus Nostoc. In the current work, six Ncps were isolated from Nostoc edaphicum strain CCNP1411. The bioactivity of these compounds was tested in vitro against 20S proteasome, a proteolytic complex that plays an important role in maintaining cellular proteostasis. Dysfunction of the complex leads to many pathological disorders. The assays indicated selective activity of specific Ncp variants. For two linear peptide aldehydes, Ncp-A2-L and Ncp-E2-L, the inhibitory effects on chymotrypsin-like activity were revealed, while the cyclic variant, Ncp-A2, inactivated the trypsin-like site of this enzymatic complex. The aldehyde group was confirmed to be an important element of the chymotrypsin-like activity inhibitors. The nostocyclopeptides, as novel inhibitors of 20S proteasome, increased the number of natural products that can be considered potential regulators of cellular processes. |
format | Online Article Text |
id | pubmed-8533403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85334032021-10-23 Nostocyclopeptides as New Inhibitors of 20S Proteasome Fidor, Anna Cekała, Katarzyna Wieczerzak, Ewa Cegłowska, Marta Kasprzykowski, Franciszek Edwards, Christine Mazur-Marzec, Hanna Biomolecules Communication Nostocyclopeptides (Ncps) are a small class of bioactive nonribosomal peptides produced solely by cyanobacteria of the genus Nostoc. In the current work, six Ncps were isolated from Nostoc edaphicum strain CCNP1411. The bioactivity of these compounds was tested in vitro against 20S proteasome, a proteolytic complex that plays an important role in maintaining cellular proteostasis. Dysfunction of the complex leads to many pathological disorders. The assays indicated selective activity of specific Ncp variants. For two linear peptide aldehydes, Ncp-A2-L and Ncp-E2-L, the inhibitory effects on chymotrypsin-like activity were revealed, while the cyclic variant, Ncp-A2, inactivated the trypsin-like site of this enzymatic complex. The aldehyde group was confirmed to be an important element of the chymotrypsin-like activity inhibitors. The nostocyclopeptides, as novel inhibitors of 20S proteasome, increased the number of natural products that can be considered potential regulators of cellular processes. MDPI 2021-10-08 /pmc/articles/PMC8533403/ /pubmed/34680116 http://dx.doi.org/10.3390/biom11101483 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Fidor, Anna Cekała, Katarzyna Wieczerzak, Ewa Cegłowska, Marta Kasprzykowski, Franciszek Edwards, Christine Mazur-Marzec, Hanna Nostocyclopeptides as New Inhibitors of 20S Proteasome |
title | Nostocyclopeptides as New Inhibitors of 20S Proteasome |
title_full | Nostocyclopeptides as New Inhibitors of 20S Proteasome |
title_fullStr | Nostocyclopeptides as New Inhibitors of 20S Proteasome |
title_full_unstemmed | Nostocyclopeptides as New Inhibitors of 20S Proteasome |
title_short | Nostocyclopeptides as New Inhibitors of 20S Proteasome |
title_sort | nostocyclopeptides as new inhibitors of 20s proteasome |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533403/ https://www.ncbi.nlm.nih.gov/pubmed/34680116 http://dx.doi.org/10.3390/biom11101483 |
work_keys_str_mv | AT fidoranna nostocyclopeptidesasnewinhibitorsof20sproteasome AT cekałakatarzyna nostocyclopeptidesasnewinhibitorsof20sproteasome AT wieczerzakewa nostocyclopeptidesasnewinhibitorsof20sproteasome AT cegłowskamarta nostocyclopeptidesasnewinhibitorsof20sproteasome AT kasprzykowskifranciszek nostocyclopeptidesasnewinhibitorsof20sproteasome AT edwardschristine nostocyclopeptidesasnewinhibitorsof20sproteasome AT mazurmarzechanna nostocyclopeptidesasnewinhibitorsof20sproteasome |